Literature DB >> 400817

Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity.

J Swanson, M Kinsbourne, W Roberts, K Zucker.   

Abstract

This report introduces a method for obtaining behavioral time-response information for a short-acting psychotropic drug (methylphenidate [Ritalin]) that is widely used to treat behaviorally hyperactive children. We used a laboratory learning task to document that between one and two hours after the administration of a single dose of methylphenidate, the drug exerts its maximum effect on performance in a learning task in the laboratory. This effect on cognitive performance dissipates within the same day. This rapid and transient effect of methylphenidate makes it possible to classify patients in a single day into those who respond favorably and those who respond adversely to the drug in terms of its effect on cognitive behavior.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 400817

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

Review 1.  Non-stimulant treatments for ADHD.

Authors:  J Biederman; T Spencer
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Effects of methylphenidate on inhibitory control in hyperactive children.

Authors:  R Tannock; R J Schachar; R P Carr; D Chajczyk; G D Logan
Journal:  J Abnorm Child Psychol       Date:  1989-10

3.  Comparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder.

Authors:  Robert L Findling; Declan Quinn; Simon J Hatch; Sara J Cameron; Heleen H DeCory; Michael McDowell
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-06-21       Impact factor: 4.785

4.  Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulations.

Authors:  Ethan M Stier; Barbara M Davit; Parthapratim Chandaroy; Mei-Ling Chen; Jeanne Fourie-Zirkelbach; Andre Jackson; Stephanie Kim; Robert Lionberger; Mehul Mehta; Ramana S Uppoor; Yaning Wang; Lawrence Yu; Dale P Conner
Journal:  AAPS J       Date:  2012-09-14       Impact factor: 4.009

5.  Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Authors:  John S Markowitz; Arthur B Straughn; Kennerly S Patrick; C Lindsay DeVane; Linda Pestreich; James Lee; Yanfeng Wang; Rafael Muniz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children.

Authors:  R Tannock; R Schachar; G Logan
Journal:  J Abnorm Child Psychol       Date:  1995-04

Review 7.  Non-stimulant medications in the treatment of ADHD.

Authors:  Tobias Banaschewski; Veit Roessner; Ralf W Dittmann; Paramala Janardhanan Santosh; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

8.  Self-paced learning in children with attention deficit disorder with hyperactivity.

Authors:  J T Dalby; M Kinsbourne; J M Swanson
Journal:  J Abnorm Child Psychol       Date:  1989-06

9.  Pharmacokinetics of methylphenidate in hyperkinetic children.

Authors:  B L Hungund; J M Perel; M J Hurwic; J Sverd; B G Winsberg
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

10.  [The health economics of attention deficit hyperactivity disorder in Germany. Part 2: Therapeutic options and their cost-effectiveness].

Authors:  M Schlander; G-E Trott; O Schwarz
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.